编程死亡干1 (PD-L1) 淋巴瘤中的表达:最先进的技术
Magda Zanelli1, Valentina Fragliasso2, Paola Parente3
1Pathology Unit, Azienda USL-IRCCS di Reggio Emilia, 42123 Reggio Emilia, Italy.
International journal of molecular sciences
|June 27, 2024
概括
针对瘤细胞的编程死亡连接体1 (PD-L1) 表达是淋巴瘤免疫检查点疗法的关键生物标志物. 了解PD-L1机制和评估对于改善这些血液性恶性瘤的治疗策略至关重要.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 病理学 病理学 病理学
背景情况:
- PD-1/PD-L1轴抑制T细胞反应,促进瘤免疫逃生.
- 瘤细胞和巨细胞上的PD-L1和PD-L2连接体介导这种免疫抑制.
- PD-L1 作为免疫检查点阻塞治疗反应的预测生物标志物.
研究的目的:
- 对各种淋巴瘤中PD-L1表达的当前知识进行审查.
- 探索PD-L1过度表达的机制及其预后意义.
- 讨论在淋巴瘤中评估PD-L1免疫组织化学的实际挑战.
主要方法:
- 对淋巴瘤中PD-L1表达研究的文献综述.
- 对PD-L1评估的免疫组织化学技术的分析.
- 讨论PD-L1表达在血液恶性瘤中的临床影响.
主要成果:
- PD-L1表达与某些淋巴瘤的治疗反应有关,如霍奇金淋巴瘤.
- 在扩散性大B细胞淋巴瘤和T细胞淋巴瘤中观察到的可变PD-L1表达和反应.
- 免疫组织化学是评估瘤细胞中PD-L1的主要方法.
结论:
- PD-L1评估对于优化淋巴瘤免疫检查点治疗至关重要.
- 需要进一步的研究来澄清PD-L1的作用,并改善其在各种淋巴瘤亚型中的评估.
- 准PD-1/PD-L1通路对于治疗血液性恶性瘤具有前景.
相关概念视频
The Intrinsic Apoptotic Pathway
6.5K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.5K
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K


